GL1X · GenesisL1 explorer

MolNFT v1 · #62429 · protein

Replacement of VAL3 in human thymidylate synthase affects its kinetic properties and intracellular stability

3EF9: “Replacement of VAL3 in human thymidylate synthase affects its kinetic properties and intracellular stability”. X-ray diffraction, 1 ligand (SO4), 3 pockets (best druggability 0.60). MolNFT v1 #62429 on GenesisL1: 3D structure…

PDB
3EF9
Type
protein
Length
264 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thymidylate synthase
EC
2.1.1.45
UniProt
P04818
Ligands
SO4
Pockets
3 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThymidylate synthase (EC 2.1.1.45)protein26430% helix, 20% strandP04818

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14410.600.7551SO4
2500.320.7713empty
3590.290.7412empty

Compared structures

  • 3EF9 · Replacement of Val3 in Human Thymidylate Synthase Affects Its Kinetic Properties and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.